J Mov Disord.  2017 May;10(2):80-86. 10.14802/jmd.17001.

Comparison of Pallidal and Subthalamic Deep Brain Stimulation in Parkinson's Disease: Therapeutic and Adverse Effects

Affiliations
  • 1Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. sjchung@amc.seoul.kr
  • 2Department of Neurology, Dongsan Medical Center, Keimyung University, Daegu, Korea.
  • 3Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.
  • 4Department of Neurology, Best Heals Hospital, Ansan, Korea.
  • 5Department of Neurology, Metro Hospital, Anyang, Korea.

Abstract


OBJECTIVE
To compare the therapeutic and adverse effects of globus pallidus interna (GPi) and subthalamic nucleus (STN) deep brain stimulation (DBS) for the treatment of advanced Parkinson's disease (PD).
METHODS
We retrospectively analyzed the clinical data of patients with PD who underwent GPi (n = 14) or STN (n = 28) DBS surgery between April 2002 and May 2014. The subjects were matched for age at surgery and disease duration. The Unified Parkinson's Disease Rating Scale (UPDRS) scores and levodopa equivalent dose (LED) at baseline and 12 months after surgery were used to assess the therapeutic effects of DBS. Adverse effects were also compared between the two groups.
RESULTS
At 12 months, the mean changes in the UPDRS total and part I-IV scores did not differ significantly between the two groups. However, the subscores for gait disturbance/postural instability and dyskinesia were significantly more improved after GPi DBS than those after STN DBS (p = 0.024 and 0.016, respectively). The LED was significantly more reduced in patients after STN DBS than that after GPi DBS (p = 0.004). Serious adverse effects did not differ between the two groups (p = 0.697).
CONCLUSION
The patients with PD showed greater improvement in gait disturbance/postural instability and dyskinesia after GPi DBS compared with those after STN DBS, although the patients had a greater reduction in LED after STN DBS. These results may provide useful information for optimal target selection for DBS in PD.

Keyword

Parkinson's disease; deep brain stimulation; globus pallidus interna; subthalamic nucleus.

MeSH Terms

Deep Brain Stimulation*
Dyskinesias
Gait
Globus Pallidus
Humans
Levodopa
Parkinson Disease*
Retrospective Studies
Subthalamic Nucleus
Therapeutic Uses
Levodopa
Therapeutic Uses
Full Text Links
  • JMD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr